← Leaderboards
Steven E Feldon
University Of Rochester
$1,242,500
Attributed
$1,242,500
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $385K · FY2005–19$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,242,500 · 2
By mechanism
R01$770,000 · 1
R03$472,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Richard P. Phipps$12,624,990
- Collynn Fremont Woeller$2,962,959
- Jennifer J Hunter$6,436,188
- Dan Gazit$6,385,050
Others in their field
Top investigators on “Antigen Presenting Cell”
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Ellis L Reinherz · Dana-Farber Cancer Institute$37,262,008
- Emil R Unanue · Washington University$29,036,066
- Mitchell Kronenberg · Cedars-Sinai Medical Center$28,767,078
- Donald L Morton · John Wayne Cancer Institute$27,764,680
Research focus
Antigen Presenting CellPathologic ProcessHelper T LymphocyteDisease /Disorder ModelLeukocyte Activation /TransformationCytokineFibroblastsTissue /Cell CultureGraves DiseaseT Cell ReceptorT LymphocyteCell Cell InteractionCell ProliferationBlood ChemistryMolecular PathologyThyroid DisorderClinical ResearchFlow CytometryHuman SubjectCellsAreaDepositionAntiinflammatory EffectAntibodies
Grant awards (5)
Thy1 expression, adpogenesis, inflammation and orbital remodeling mechanisms in Thyroid Eye Disease$385,000
R01 · FY2019 · EY · contact PI
Thy1 expression, adpogenesis, inflammation and orbital remodeling mechanisms in Thyroid Eye Disease$385,000
R01 · FY2018 · EY · contact PI
A novel in vitro model of thyroid ophthalmopathy$157,500
R03 · FY2005 · EY
A novel in vitro model of thyroid ophthalmopathy$157,500
R03 · FY2004 · EY
A novel in vitro model of thyroid ophthalmopathy$157,500
R03 · FY2003 · EY